{
  "trial_id": "NCT04343313",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Moderately severe or severe mitral regurgitation (MR Grade \u2265 3+)",
      "label": "met"
    },
    {
      "criterion": "Symptomatic mitral regurgitation (NYHA Class II-IV), despite guideline-directed medical therapy (GDMT) determined by the local multidisciplinary heart team",
      "label": "met"
    },
    {
      "criterion": "Age \u2265 21",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Prior transseptal intervention with occlusion device currently implanted",
      "label": "triggers"
    },
    {
      "criterion": "Implanted with venous stents (iliac and femoral) including inferior vena cava (IVC) filter or congenital abnormalities of the IVC that would preclude ability for transfemoral access with the delivery system",
      "label": "triggers"
    },
    {
      "criterion": "Evidence of intracardiac, inferior vena cava, or femoral venous mass, thrombus, or vegetation",
      "label": "triggers"
    }
  ],
  "notes": "Patient has severe mitral regurgitation and is symptomatic despite medical therapy. However, they have a history of prior transseptal intervention with an occlusion device implanted, which makes them ineligible for the study.",
  "_meta": {
    "topic_id": "12",
    "trial_id": "NCT04343313",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}